They opined that the “blood AIM released from IgM contributes to suppression of obesity and fatty liver as in AKI, whereas macrophage-derived non-circulating AIM mainly prevents HCC development” [25]. This evidence concerns the gene CD40LG and hepatocellular carcinoma.